Page 5 - Phar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phar Today - Breaking & Trending Today

Exclusive: Delays getting higher dose Wegovy to patients reported by US doctors

Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week, suggesting a new supply challenge for the popular medicine. ....

United States , City Of , United Kingdom , San Francisco , New York , Alicia Shelly , Patrick Wingrove , Caroline Humer , Novo Saxenda , Erin Loverher , Elissa Welle , Maggie Fick , Disha Narang , Holly Lofton At New York University Langone , Novo Nordisk Novob Co Wegovy , Wellstar Health System , Thomson Reuters Trust Principles , Barclays Research , Novo Nordisk , Robert Kushner , Northwestern University , Feinberg School , Amazon Pharmacy , Holly Lofton , New York University Langone , Thomson Reuters Trust ,

Exclusive: MoonLake Immunotherapeutics explores sale-sources

MoonLake Immunotherapeutics , a developer of an antibody-derived treatment for inflammatory skin conditions, is exploring a sale, according to people familiar with the matter. ....

New York , United States , David Carnevali , Moonlake Immunotherapeutics , Merck Kga , Abbvie Humira , Josie Kao , Abbvie Inc , Prometheus Biosciences Inc , Merck Co , Thomson Reuters Trust Principles , Eli Lilly , Dice Therapeutics , Thomson Reuters Trust , Rhpi Mergers Acquisitions ,

U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 mln

An influential U.S. drug pricing watchdog raised the price estimate of two experimental gene therapies from Vertex Pharmaceuticals /CRISPR Therapeutics and bluebird bio to as much as $2.05 mln, saying the new price can be cost effective to treat sickle cell disease. ....

United States , Bhanvi Satija , Vertex Pharmaceuticals , Institute For Clinical , Thomson Reuters Trust Principles , Economic Review , David Rind , Biomarin Pharmaceutical , Thomson Reuters Trust , Rhpi Biopharma ,

FDA approves Perrigo's contraceptive as first over-the-counter pill in US

The U.S. Food and Drug Administration on Thursday approved the first over-the-counter contraceptive pill, paving the way for millions of women in the country to purchase birth control without prescription. ....

Arun Koyyur , Manas Mishra , Drug Administration On , Us Supreme Court , Thomson Reuters Trust Principles , Drug Administration , Thomson Reuters Trust , Nrlin Ogov , Rhpi Approvals , Rhpi Regulatory , Ef Business Future Of Health , Nrlpa Ohlt , Reuters Legal , Nrlpa Opub , Rsbi Regulatory Oversight , Rhpi Public Health , Rhpi Health Equity ,

US govt tells vaccine makers to price updated COVID shots reasonably

COVID vaccine makers should price their updated shots for the fall at a reasonable rate that would reflect the benefits they received through government investments, the U.S. Department of Health and Human Services (HHS) said on Thursday. ....

United States , Shinjini Ganguli , Shailesh Kuber , Bhanvi Satija , Access Program , Drug Administration , Us Department Of Health , Human Services , Thomson Reuters Trust Principles , Disease Control , Thomson Reuters Trust , Nrlin Ocov , Rhpi Public Health , Ef Business Future Of Health , Nrlpa Ohlt , Nrlpa Opub , Reuters Legal ,